A patient's experience with hospital care and quality of integrated care delivery over time was related to quality of life 3 months after discharge from the hospital, according to a new study.
A recent study published in BMS Health Services Research found that a patient’s experience with hospital care and quality of integrated care delivery over time was related to quality of life 3 months after discharge from the hospital.
Researchers reported that older patients who leave the hospital with higher levels of satisfaction regarding the received hospital care and integrated care delivery have higher quality of life within those first 3 months post-hospitalization.
“These results underscore the importance of enhancing older patients’ experiences with care delivery,” the authors wrote in their report.
The researchers especially noted that marriage, quality of life within 48 hours of hospital admission and experiences with hospital care and quality of integrated care delivery over the 3-month period and were positively related to quality of life by the 3-month mark post-discharge.
While healthcare improvement and various intervention programs have gained popular use among care providers, researchers explained that professionals find it difficult to balance cost and quality when caring for patients.
“The question for most professionals is how to enhance patients’ experiences with (integrated) care delivery while keeping costs low and make efficient use of resources,” the authors added.
Pulmonary Hypertension Subtypes Show Distinct PA Flow Hemodynamics
March 21st 2025Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) remodeling in pulmonary arterial hypertension and other types of pulmonary hypertension.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
FDA Approves Vutrisiran to Mitigate Cardiomyopathy-Related Risks and Conditions
March 21st 2025In a recent decision, the FDA approved vutrisiran (amvuttra), making it the only approved therapy for adults with hereditary transthyretin-mediated amyloidosis (ATTR-CM) or wild-type cardiomyopathy.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen